Clinical Trial Detail

NCT ID NCT04221503
Title Niraparib/TTFields in GBM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pennsylvania
Indications

glioblastoma multiforme

Therapies

Niraparib

Age Groups: adult senior

No variant requirements are available.